Nikolay Alemasov

Dr. Nikolay Alemasov

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2020 in The Protein Journal
Verified
Journal Article
Closed access
PDF file
APAnna S. Pavlova
Anna S. Pavlova
GOGeorgii D. Ozhegov
Georgii D. Ozhegov
GAGeorgij P. Arapidi
Georgij P. Arapidi
IBIvan Butenko
Ivan Butenko
EFEduard S. Fomin
Eduard S. Fomin
AKAirat Kayumov
Airat Kayumov

25 February 2021 in Metabolites
Verified
Journal Article
Open access
PDF file
Artem D. RogachevArtem D. Rogachev
Artem D. Rogachev
NANikolay Alemasov
Nikolay Alemasov
VIVladimir A. Ivanisenko
Vladimir A. Ivanisenko
NINikita Ivanisenko
Nikita Ivanisenko
EGEvgeniy V. Gaisler
Evgeniy V. Gaisler
APAndrey G. Pokrovsky
Andrey G. Pokrovsky
This work compares the metabolic profiles of plasma and the cerebrospinal fluid (CSF) of the patients with high-grade (III and IV) gliomas and the conditionally healthy controls using the wide-range targeted screening of low molecular metabolites by HPLC-MS/MS. The obtained data were analyzed using robust linear regression with Huber’s M-estimates, and a number of metabolites with correlated content in plasma and CSF was identified. The statistical analysis shows a significant correlation of metabolite content in plasma and CSF samples for the majority of metabolites. Several metabolites were shown to have high correlation in the control samples, but not in the glioma patients. This can be due to the specific metabolic processes in the glioma patients or to the damaged integrity of blood-brain barrier. The results of our study may be useful for the understanding of molecular mechanisms underlying the development of gliomas, as well as for the search of potential biomarkers for the minimally invasive diagnostic procedures of gliomas.

5 February 2018 in BMC Structural Biology
Verified
Journal Article
Open access
PDF file
NANikolay Alemasov
Nikolay Alemasov
NINikita V. Ivanisenko
Nikita V. Ivanisenko
SRSrinivasan Ramachandran
Srinivasan Ramachandran
VIVladimir A. Ivanisenko
Vladimir A. Ivanisenko
So far, little is known about the molecular mechanisms of amyotrophic lateral sclerosis onset and progression caused by SOD1 mutations. One of the hypotheses is based on SOD1 misfolding resulting from mutations and subsequent deposition of its cytotoxic aggregates. This hypothesis is complicated by the fact that known SOD1 mutations of similar clinical effect could be distributed over the whole protein structure. In this work, a measure of hydrogen bond stability in conformational states was studied with elastic network analysis of 35 SOD1 mutants. Twenty-eight hydrogen bonds were detected in nine of 35 mutants with their stability being significantly different from that with the wild-type. These hydrogen bonds were formed by the amino acid residues known from the literature to be located in contact between SOD1 aggregates. Additionally, residues disposed between copper binding sites of both protein subunits were found from the models to form a stiff core, which can be involved in mechanical impulse transduction between these active centres. The modelling highlights that both stability of the copper binding site and stability of the dimer can play an important role in ALS progression.

1 October 2017 in Journal of Molecular Graphics and Modelling
Verified
Journal Article
Closed access
NANikolay Alemasov
Nikolay Alemasov
NINikita V. Ivanisenko
Nikita V. Ivanisenko
VIVladimir A. Ivanisenko
Vladimir A. Ivanisenko

1 January 2022 in Journal of Molecular Graphics and Modelling
Verified
Journal Article
Closed access
NANikolay Alemasov
Nikolay Alemasov
VTVladimir S. Timofeev
Vladimir S. Timofeev
NINikita V. Ivanisenko
Nikita V. Ivanisenko
NKNikolay A. Kolchanov
Nikolay A. Kolchanov
VIVladimir A. Ivanisenko
Vladimir A. Ivanisenko

17 March 2016 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
NANikolay Alemasov
Nikolay Alemasov
NINikita V. Ivanisenko
Nikita V. Ivanisenko
SMSergey Medvedev
Sergey Medvedev
SZSuren Zakian
Suren Zakian
Nikolay KolchanovNikolay Kolchanov
Nikolay Kolchanov
VIVladimir A. Ivanisenko
Vladimir A. Ivanisenko
One of the reasons for the death of motor neurons of the brain and spinal cord in patients with amyotrophic lateral sclerosis is known to be formation of subcellular protein aggregates that are caused by mutations in the SOD1 gene. Patient survival time was earlier shown to have limiting correlation with thermostability change of SOD1 mutant forms of patients’ carriers. We hypothesized that aggregation of mutant SOD1 may occur not only due to the protein destabilization, but through formation of novel interatomic bonds which stabilize “pathogenic” conformations of the mutant as well. To estimate these effects in the present paper, we performed statistical analysis of occupancy of intramolecular hydrogen bonds, hydrogen bonds between the protein and water molecules, and water bridges with use of molecular dynamics simulation for 38 mutant SOD1 forms. Multiple regression model based on these kinds of bonds demonstrated correlation with patient survival time significantly better (R = .9, p-value < 10−11) than the thermostability of SOD1 mutants only. It was shown that the occupancy of intramolecular hydrogen bonds between amino acid residues is a key determinant (R = .89, p-value < 10−10) in predicting patients’ survival time.